Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UPDATE 2-FTSE 100 ends higher on GlaxoSmithKline boost; midcaps at record highs

Published 15/04/2021, 09:24
Updated 15/04/2021, 17:30
© Reuters.

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Activist investor buys multi-billion pound stake in GSK -
report
* Entain gains as quarterly online net revenue jumps
* Travis Perkins rises on 17% growth in Q1 like-for-like
sales
* FTSE 100 up 0.6%, FTSE 250 adds 0.5%

(Updates to close)
By Devik Jain and Shashank Nayar
April 15 (Reuters) - London's FTSE 100 ended higher on
Thursday on the back of gains in healthcare heavyweight
GlaxoSmithKline and mining stocks, while hopes of a faster
economic recovery lifted the mid-cap index to record highs.
The blue-chip index .FTSE rose 0.6%, with GlaxoSmithKline
GSK.L advancing 5% to become the top gainer after the European
Medicines Agency said it was reviewing available data on the use
of the company's monoclonal antibody to treat COVID-19
patients. The gains also came after a report that activist hedge fund
Elliott Management took a multi-billion pound stake in the
British pharmaceutical firm GSK.L . Precious and base metal miners .FTNMX551030 .FTNMX551020
added 2.6% and 1.3%, respectively, as they benefited from
higher metal and gold prices. MET/L GOL/
"I think it's only a matter of time when the FTSE breaches
the 7,000 mark," said Michael Hewson, chief market analyst at
CMC Markets.
"The catalyst for the game is pretty decent macro numbers
out of the U.S., while there is exuberance in minds of the
investors with regard to economic recovery and the reopening
trade."
The domestically focussed mid-cap FTSE 250 index .FTMC
climbed 0.5%, led by gains in consumer discretionary and
industrial stocks.
Britain's biggest building materials seller Travis Perkins
TPK.L gained 2.2% and was one of the biggest boosts to the
mid-cap index after it said its first-quarter like-for-like
sales, excluding the Wickes unit, rose 17.4%. The FTSE 100 has gained 8.1% so far this year as investors
bet that speedy vaccine rollouts, policy support from the
government and businesses reopening would fuel a stronger
economic rebound from the pandemic-driven crash.
British gambling group Entain ENT.L gained 1.1% after its
quarterly online net revenue jumped 33%, even as shop closures
hit its total net gaming revenue.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.